Clinicopathological characteristics and prognostic analysis of PIK3CA mutation in breast cancer patients in Northwest China
Wei Lv(Shandong University of Traditional Chinese Medicine), Shuqun Zhang(Nanjing Agricultural University), Fei Wu(Tongji University), Xi Chen(Tongji University), Xuan Liu(Shanghai University of Traditional Chinese Medicine), Yaofeng Jin(Xi'an Jiaotong University), Feng Cong(First Affiliated Hospital of Heilongjiang University of Chinese Medicine), Chong Du(Second Affiliated Hospital of Xi'an Jiaotong University), Xingcong Ma(University of North Carolina at Chapel Hill), Yinbing Zhang(Sichuan University)
Cited by 6
Related Papers
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations
|Nature Genetics|2012|878
Rapid Avr9- and Cf-9–Dependent Activation of MAP Kinases in Tobacco Cell Cultures and Leaves: Convergence of Resistance Gene, Elicitor, Wound, and Salicylate Responses
|The Plant Cell|1999|455
Bioengineered Boronic Ester Modified Dextran Polymer Nanoparticles as Reactive Oxygen Species Responsive Nanocarrier for Ischemic Stroke Treatment
|ACS Nano|2018|300
CD44 splice isoform switching determines breast cancer stem cell state
|Genes & Development|2019|233